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Abstract 
Epilepsy is a major public health issue 
especially in developing African countries. 
The etiologies and approach to 
management are significantly different 
in developed and developing 
countries, with infectious causes and 
treatment with phenobarbitone being 
the peculiarities of the developing sub-
Saharan African countries.  This 
review emphasizes the peculiar 
etiological considerations, epidemiology 
and treatment options of epilepsy in 
Nigeria, and also compares these with 
the practice of epilepsy management 
in other African and developed 
countries. 
INTRODUCTION 
 Epilepsy is the most common 
non-infectious neurologic disease in 
developing African countries, 
including Nigeria 1,2 and it remains a 
major medical and social problem 1.  
Historically, epilepsy was believed to 
be a sacred disease that is the result 
of the invasion of the body by a god. It 
was thought that only a god could 
deprive a healthy man of his senses, 
throw him to the ground, convulse him 
and then rapidly restore him to his 
former self again3. The word `lunatic' 
was first applied to sufferers of 
epilepsy as gods were thought to 
occupy heavenly spheres, one of 
which was the moon. In contrast, mad 
people were referred to as `maniacs' 
whose madness was a result of 
invasion of the body by devils or evil 
spirits. In the Gospel according to 
Saint Mark 4, it was a foul spirit that 
was cast out of the young man with 
fits. The ‘Dictator Perpetuus’ of the 
Roman Empire, the great Julius 
Caesar likely had epilepsy on the 
basis of documented four attacks that 
were probably complex partial 
seizures. Also, it is possible that he 
had absence attacks as a child and as 
a teenager. His son, Caesarion, and 
his great-great-great grandnephews 
Caligula and Britannicus also had 
seizures. The etiology of epilepsy in 
this Julio-Claudia family is probably 
linked to inheritance5. 
 This historical legacy has 
continued to influence public attitude 
to epilepsy making it a dreaded 
disease. These beliefs have resulted 
in patients with epilepsy (PWE) being 
ostracized, stigmatized and misunderstood. 
The social implications are serious. 
For instance, in Madagascar, patients 
with epilepsy are refused burial in the 
family grave2. In many African 
countries, the PWE is an out-cast 6 as 
Africans believe that the disease 
results from visitation of the devil, 
effect of witch-craft, the revenge of an 
aggrieved ancestral spirit or 
consumption of something harmful in 
utero 7,8. Suicide or attempted suicide 
is not uncommon among Nigerians 
who suffer from epilepsy 9,10. The 
patient with epilepsy is likely to drop 
out of school, lose his job, finds it 
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impossible to marry, loses his wife or 
her husband, and be tormented to the 
extent of becoming a vagrant 
vagabond 2,9,10. 
 The remarkable issue raised by 
Hippocrates' famous treatise on the 
`Sacred Disease' was his belief that 
epilepsy was not sacred, that the 
brain was the seat of the disease. In 
the latter half of the nineteenth 
century, Hughlings Jackson 11 defined 
epilepsy on the basis of a neuronal 
theory. About three decades later, 
William Gowers 12 observed a link 
between epilepsy and cognitive 
deterioration. He noted that defective 
memory, especially for recent 
acquisitions and weakened capacity 
for attention are frequently 
encountered cognitive impairments in 
epileptic patients. This observation 
was not novel as Tissot in 1770 13 in 
his `Traite' de L`Epileptic' wrote that 
he had never seen a patient with 
epilepsy whose fits were not very rare 
not complaining about a weakening of 
memory. 
Definition 
 According to the World Health 
Organization dictionary of Epilepsy, 
epilepsy is defined as a `chronic 
disorder of the central nervous system 
of various etiologies characterized by 
recurrent seizures due to excessive 
discharge of cerebral neurones. 
Single or occasional seizures as well 
as those occurring during an acute 
illness should not be classified as 
epilepsy 14. 
Epidemiology 
 At a conservative estimate, 50 
million people worldwide have 
epilepsy with an annual incidence 
ranging from 20 to 70 cases per 
100,000 15 and the point prevalence of 
0.4 to 0.8 percent16. The incidence 
rates are highest in childhood, 
plateaus from the age of 15 to 65 
years, and rise again among the 
elderly15,16. Most patients suffering 
from epilepsy in African countries 
prefer anonymity and are reluctant to 
disclose their condition because of the 
stigma attached to the disease2. This 
factor affects the prevalence rates 
hence there is likelihood that most of 
the reported prevalence rates 
represent a `tip of the ice-berg' as the 
chances of under-reporting are high. 
The prevalence rates of epilepsy 
reported in Africa are based on 
surveys of defined communities and 
hospital admissions. 
 The prevalence of epilepsy is 
particularly high in developing 
countries especially in Latin America 
and several African countries, notably 
Liberia, Nigeria and United Republic 
of Tanzania 1 compare with the 
prevalence rates of between 4 and 6 
per 1000 which have been reported 
among Caucasians16. In Nigeria, its 
prevalence, based on defined 
communities, varies from 15 to 37 per 
10003. However one of the early 
publications17 on the prevalence of 
epilepsy in Nigeria reported a 
prevalence of between 8 and 13 per 
1000 inhabitants in the urban 
communities of Lagos, but with a 
computed rate of 3.1 per 1000. 
Osuntokun et al18 reported a 
prevalence rate of 5.3 per 1000 
among the inhabitants of Igbo-ora, a 
community with comprehensive health 
facilities, with the highest age-specific 
prevalence ratio occurring below the 
age of 20 years i.e. within 5 to 14 
years age group. This prevalence rate 
is lower than what obtains in most 
rural African communities (refer Table 
1) and similar to that of Western 
countries. The lower prevalence rate 
is probably due to the improved health 
facilities in this community. In another 
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community-based study, Longe and 
Osuntokun19 reported a prevalence 
rate of 6.2 per 1000 among the 
residents of Udo, a rural Community 
of Edo-speaking people in Nigeria. 
 The age distribution in 
Nigerians appears similar to that 
described among the Caucasians. 
Between 70% and 85% of PWE have 
onset of seizures below 30 years of 
age2. Osuntokun et al 20 and Udofia 3 
noted that the onset in 68% of 
patients was in the first and second 
decades of life. Obembe and Ahmed21 
confirmed this among children over 5 
years of age with a prevalence of 
82%. Among adult Nigerians, a study 
reported a mean age of 21 years with 
dominance of partial seizures (53.3%)22. 
 Most African studies reported a 
slight male excess 2. It is thought that, 
in most parts of Africa, males more 
readily come to the hospital for socio-
economic reasons and hence predominate 
in the hospital populations. This 
pattern holds true for Nigerians with 
epilepsy. The male sex preponderance 
may also be due to occupational and 
social exposure to epileptogenic 
insults such as cranial trauma and 
alcohol. 
Epilepsy tends to be more common in 
the lower socio-economic groups 23. 
Shomansky and Glaser 24 found an 
excess incidence of epilepsy among 
the poor blacks in United States of 
America. Several studies reported in 
Africa also confirmed a higher 
prevalence of epilepsy among rural 
dwellers 2,25,26. These epidemiological 
findings are of importance as they 
imply that, at least part of the burden 
of the incidence of epilepsy can be 
solved by preventive methods to 
improve social health as certain risk 
factors have been identified to 
increase the prevalence of epilepsy. 
In a case-control study in which 155 
Nigerian epileptic patients were 
compared with age and sex - matched 
controls, febrile convulsions and head 
trauma were significant risk factors for 
epilepsy, while childhood immunization 
was significantly associated with 
decreased prevalence27. Other studies 
have confirmed the importance of birth 
asphyxia, intracranial infections, 
hereditary factors and head injuries as 
important risk factors 1,2,28. Many of 
these factors are preventable or 
modifiable and the introduction of 
appropriate measures to achieve this 
could lead to a substantial decrease in 
the incidence of epilepsy in developing 
countries. 
 
Table I: Prevalence of epilepsy in 











4 Bird et al (1962) 
Ghana 4 Haddock (1973) 
Uganda 4 Orley (1970) 
Zimbabwe 7.4 Levy et al (1964) 
Ethiopia 
(Rural) 
8 Giel (1968) 
Ethiopia 
(Urban) 
5 Giel (1968) 
Senegal 3 – 8 Collomb et al 
(1970) 
Tanzania 1 Smartt (1959) 
Tanzania 20 Jilek & Jilek 
(1970) 
Kenya 10 - 18 Miyangi (1995) 
Nigeria 
Urban 










 Idiopathic epilepsy still remains 
the commonest in all age groups, 
though the frequency of symptomatic 
epilepsy progressively rises with age2. 
Idiopathic epilepsy constitutes 55 - 
60% of epilepsy reported in Nigerians2.  
In other parts of the world, about 30% 
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of patients with seizure have an 
identifiable neurological or systemic 
disorder, and the remainders have 
either idiopathic or cryptogenic 
epilepsy 29. 
Genetics 
 Several studies conducted in 
recent times showed that inherited 
forms of epilepsy account for about 
20% of all patients with epilepsy, 
particularly in children 30. Although the 
premise that heredity plays an 
important role in epilepsy was first 
noted by Hippocrates in 450 B.C. in 
his treatise on `The Sacred Disease' 
where he stated that, `It is thus with 
regard to the disease called Sacred; it 
appears to me no more divine nor 
more Sacred than other diseases. Its 
origin is hereditary, like that of other 
diseases'. Now we know that epilepsy 
is a component of the phenotype in 
over 100 mendelian disorders, but the 
most common genetic epilepsies 
display a ‘complex’ non-mendelian 
pattern of inheritance. These include 
several well-defined syndromes such 
as juvenile myoclonic epilepsy (JME), 
absence epilepsy and benign 
childhood epilepsy with centrotemporal 
spikes. Many of the recessively 
inherited disorders of lipid and 
aminoacid metabolism may be 
associated with seizures 31,32, for 
example in ceroid lipofucinoses and 
Tay Sach's disease, both commonly 
associated with myoclonic seizures. 
Other recessively inherited disorders 
like tuberous sclerosis33, neurofibromatosis 
and Lafora body disease are also 
associated with seizures 32. 
 The basic neurobiological basis 
of these common familial epilepsies is 
entirely unknown but recent advances 
in genetics and molecular biology 
have provided new methods for 
investigation of human inherited 
diseases known only by their 
phenotype. Recently mutations in the 
subunit of the glycine receptor have 
been reported in patients with 
hyperekplexia, a neurological disorder 
with features in common with epilepsy30.  
The role of inheritance has been more 
extensively studied in typical absence 
seizures than in any other seizure 
type. Metrakos and Metrakos 34 found 
generalised spike and wave activity in 
the eletro- encephalograms (EEG) of 
37% of siblings of patients as 
opposed to 9% in the control group. 
Furthermore, a 50% risk of inheriting 
the gene for the spike and wave 
abnormality on the EEG of offsprings 
and siblings of patients, and a 12% 
risk of actually having one or more 
seizures were reported34. 
The role of genetics in primary 
generalized tonic - clonic seizures 
(GTC) has also been documented31,34. 
The mode of inheritance appears to 
be heterogenous, with both polygenic/ 
multifactorial, and unrecognized single- 
gene factors all playing roles. There is 
a well-documented relationship between 
primary generalized seizure type, 
particularly typical absence seizures, 
and primary generalized tonic - clonic 
seizures. Generalized tonic seizures 
commonly occur in patients with 
typical absence seizures. In addition, 
relatives of patients with typical 
absence seizures have a higher risk 
for GTC seizures as well as absence 
seizure than the general population 34. 
Photosensitive epilepsy, a form of 
reflex epilepsy that is precipitated by 
flickering light and that occurs around 
puberty with a higher incidence in girls 
than in boys, has been reported to be 
familial 35. 
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 Although there is general 
agreement that genetic factors are 
important in generalized seizure 
disorders, partial seizures have been 
attributable mainly to acquired causes 
such as asphyxia, infection, trauma, 
tumor and haemorrhage1,18,36. Some 
workers had, however, reported the 
interaction of environmental and 
hereditary influences in partial 
seizures 32,34. Rimoin and Metrakos 37 
reported that patients who suffered 
brain insults and did not have seizures 
had a lower familial predisposition to 
seizures than those who did have 
seizures. Furthermore, 15% of siblings 
of children with complex partial 
seizures were reported to have had 
seizures. 
 The literature concerning the 
genetics of febrile seizures is 
voluminous and controversial. It is 
however generally agreed that there is 
an increased incidence of febrile 
seizures among the relatives of 
children with febrile seizures 31. A 
positive family history for febrile 
seizures can be elicited in 25 to 40% 
of patients with afebrile seizures 16. 
There is scanty information available 
on genetic epidemiology of epilepsy in 
Nigerians, but there are reports of 
tuberous sclerosis among Nigerians 
with epilepsy28,33. 
Infections 
 The commonest cause of 
symptomatic epilepsy remains central 
nervous system infections, mainly 
bacterial and viral meningitis, 
encephalitis, neurosyphilis, brain 
abscess and tuberculosis.  These 
infections accounted for 10% to 20% 
of cases of epilepsy reported in 
Africa2. Most of the acute 
presentations of seizures in the 
tropics, where health facilities are 
lacking, especially in the rural and 
suburban communities, are due to 
CNS infections.  Incidentally, Human 
immunodeficiency virus infection (HIV) 
is increasing steadily in Africa, with 
the recent WHO report stating that 
`11.3 million cases out of 17 million 
worldwide are found in Africa with 
South Africa, Uganda, Kenya and 
Nigeria leading other African 
Countries'38. It is now clear that HIV 
infection will be, or already is, a much 
greater problem in developing tropical 
countries. It may lead to epilepsy by 
direct invasion of the brain, as in HIV 
encephalopathy, or as a consequence 
of opportunistic infections, as in 
toxoplasmosis. 
 Although there is a high 
incidence of parasitic infections in 
Nigeria, there is little evidence that 
these parasites commonly cause 
epilepsy locally 36. There are however, 
many reports from other parts of the 
world, especially other developing 
countries, incriminating parasites in 
the causation of epilepsy 39. 
Cysticercosis is the commonest cause 
of epilepsy in some parts of the world 
due to the introduction of computed 
tomography (CT) in the 1970s and 
early 1980s which allowed for its 
detection. Epilepsy is the commonest 
presentation of neuro cysticercosis, 
frequently as an isolated clinical sign, 
to the extent that prevalence figures 
for idiopathic epilepsies in endemic 
regions cannot be accepted unless 
subjects have been examined with 
CT. This infection has been rarely 
reported in Nigeria unlike her 
neighbours, Cameroun and Togo, 
where cysticercosis was responsible 
for significant proportions of epilepsy 
cases40,41. 
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Echinococcosis and schistosomiasis 
may also parasitize the brain, but they 
rarely are a cause of epilepsy39. 
Cerebral schistosomiasis predominantly 
occurs in Asia and causes seizure as 
an acute meningoencephalitis or as 
chronic single or multiple granulomata. 
Hepatic schistosomiasis leading to 
portal hypertension presents as an 
encephalopathy that appears to occur 
early in infection, and may also present 
with seizures. The relationship between 
Trypanosoma Cruzi, the agent of 
Chaga's disease and epilepsy, is 
indirect, through cardiac embolization 
of the brain. In the African Trypanosoma 
infection, sleeping sickness, seizures 
may occur in the late stages and 
possibly also as sequelae in survivors39. 
Seizures are one of the hallmarks of 
the clinical presentation of cerebral 
malaria, due to Plasmodium falciparum. 
P. Vivax, the more common agent of 
malaria in Latin America, may be the 
commonest infection associated with 
febrile seizures in this region, 
although this is not proven 39. Thirty-
one percent of symptomatic epilepsies 
reported by Dada 36 were due to CNS 
infections, cerebral abscess and 
malaria, while 22% of patients with 
temporal lobe epilepsy had febrile 
convulsions in childhood from malaria. 
Other parasitic infection that have 
been implicated include toxocariasis, 
ascariasis, filariasis and hydatid cyst36,39.  
In a publication by Danesi 28 an 
incidence of 2.1% and 21.9% was 
reported for CNS infections and febrile 
convulsions respectively while 32.8% 
and 24.6% were documented in 
another series by Obembe and 
Ahmed 21. These studies were carried 
out in the southern and northern parts 
of Nigeria respectively. Cerebrospinal 
meningitis is commoner in the north 
hence, the higher incidence in the 
latter study. Seizures are a common 
manifestation of cerebral tuberculosis, 
but not of tuberculous meningitis. 
Cerebrospinal fluid (CSF) studies and 
CT brain scans are the mainstay of 
diagnosis. 
Trauma 
 Trauma and hypoxia are 
among the commonest causes of 
epilepsy in Nigeria. These factors may 
act alone or together in the perinatal 
period owing to poor obstetric care, or 
throughout life in acts of violence at 
home, work and in traffic accidents. 
Birth trauma can cause epilepsy 
following excessive moulding of the 
scalp and asphyxia with subsequent 
damaging effects on the hippocampus 
and amygdala resulting in incisural 
sclerosis. It accounts for 1 - 2% of 
symptomatic epilepsies in Africa 2. In 
a large series of patients, it accounted 
for 3.4% 28. 
Nigeria and the East African countries 
have the highest rate of automobile 
accidents per million-vehicle miles in 
the world and consequently post 
traumatic epilepsy is becoming 
increasingly common. The occurrence 
of seizure in the first week after head 
injury indicates a higher likelihood of 
another seizure. 20% will have a 
second seizure if the first seizure 
occurs between second and seventh 
week after head injury42. It accounts 
for between 8% and 12% of 
symptomatic epilepsies in Nigeria21,28. 
Tumours 
 Cerebral tumours account for 3 
- 10% of symptomatic epilepsies in 
Africa2. With the introduction and 
installation of CT in some tertiary 
institutions in several African 
countries, more cases of epilepsy 
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secondary to cerebral tumours are 
becoming obvious. 
Vascular 
 Vascular lesions account for 6 - 
20%2 in Africa but lower incidence 
rate of 3.3%21 and 1.3%28 were 
obtained among Nigerian PWE. 
Seizures occur in 15% of patients with 
cerebral infarction and become 
chronic in less than 5%. Inflammatory 
vasculitis (e.g. polyarteritis nodosa, 
lupus erythematosus), subdural 
hematoma, arteriovenous malformation 
and intracerebral hemorrhage can 
present as seizures. 
Metabolic 
 Metabolic derangements, such 
as pyridoxine deficiency which is 
associated with increased glutamic acid 
and reduced gamma aminobutyric 
acid (GABA) levels in the brain, may 
result in seizures. Other metabolic 
causes of epilepsy include 
aminoaciduria, hypoglycemia, hypocalcemia, 
hypomagnesemia, uraemia, alkalosis 
and water intoxication42. Insulinoma, 
causing hypoglycemia may rarely 
present with epilepsy 43. 
Drugs 
 Generalized seizures have 
been reported in non-epileptic 
Nigerian subjects with normal EEGS 
after toxic doses of chloroquine39, 
more rarely with therapeutic doses44, 
and even during prophylactic 
treatment. Patients with epilepsy of 
low seizure threshold may be 
especially prone, which has prompted 
suggestions that the drug is 
contraindicated in such cases. The 
mechanism for these effects of 
antimalarial drugs is unclear, but 
chloroquine inhibits glutamate 
dehydrogenase activity. Mefloquine 
which has been associated with an 
increase in seizure frequency in 
epileptic patients reduces the half-life 
of valproate 39. 
Seizure types 
The clinical manifestations of patients 
often depend on the seizure types. 
These clinical features are outlined 
under the subheadings of partial 
epilepsy and generalised epilepsy. 
Partial Epilepsy 
The clinical manifestations of 
partial seizures are determined by the 
cortical area involved. For example, 
seizures arising from the occipital 
region present with visual 
phenomena, those from the precentral 
gyrus with motor phenomena, and 
those from the postcentral gyrus with 
sensory symptoms. Seizures arising 
from the temporal lobe are usually 
associated with altered state of 
consciousness and therefore are 
complex partial seizures. Of the 
simple partial seizures, those with 
motor symptomatology remain the 
most common type. The seizures may 
involve only small groups of muscles, 
such as rhythmic twitching of a single 
finger or part of the tongue, or multiple 
muscle groups, such as clonic activity 
of the arm or leg. Rarely, there may 
be inhibition of tone, and rather than 
tonic or clonic movements, the patient 
becomes limp in one or two 
extremities. Versive seizures are 
characterized by forced turning of the 
head or eyes. 
 Simple partial seizures are less 
frequent than complex partial seizures 
in most series 21,28,45 reported among 
Nigerian patients. Among 945 patients 
reviewed by Danesi 28 partial seizures 
constitute the larger group with 
complex partial seizures accounting 
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for 76.6 percent, and this observation 
was consistent with the series 
published by Osuntokun et al 18 and 
Obembe et al21. This higher proportion 
of complex partial seizures is probably 
due to higher incidence of birth injuries, 
central nervous system infections and 
more importantly, recurrent childhood 
febrile convulsions 28. Focal motor 
seizures may remain strictly localized 
or may spread to contiguous cortical 
areas, producing a sequential 
involvement of body parts, formerly 
known as a `jacksonian march'. 
Following partial motor seizures, there 
may be paralysis of the muscle 
groups previously involved in the 
seizure. This weakness, termed 
Todd's paralysis, may last from 
minutes to hours and is helpful in 
determining the focus of the seizures. 
 Two syndromes in which partial 
motor seizures are major component 
are, namely; (a) Benign rolandic 
epilepsy, which occurs in childhood 
and characterized with partial motor 
seizures, with or without secondary 
generalization, and associated with 
central and mid temporal spikes. It is 
frequently familial and has excellent 
prognosis, and (b) a syndrome 
described by Aicardi and Chevrie46 
which occurs in children between 2 
and 6 years of age and characterized 
with simple partial seizures which 
occur in association with atypical 
absences and myoclonic - atonic 
seizures. EEG commonly demonstrates 
focal abnormalities during the wakeful 
state and an almost continuous, 
diffuse slow spike - and - wave pattern 
during sleep. The prognosis for 
remission of the seizures is favorable. 
 Automatic behavior or psychomotor 
symptoms occur frequently in complex 
partial seizures (CPS). It consists of 
involuntary motor activities occurring 
when consciousness is impaired 
during either the ictal or the postictal 
period. Some patients with CPS and 
their parents are aware of an 
impending seizure days or hours 
before the event. This seizure 
prodrome may consist of headaches, 
irritability, insomnia, changes in 
personality or activity level, or a 
feeling of impending doom. Prodromes 
preceding CPS are not as common as 
before generalized tonic-clonic 
seizures. The prodrome is not an ictal 
event and must be differentiated from 
an aura, which is an ictal 
phenomenon. The physiological basis 
of the prodrome has not been 
established.  
 Aura is the portion of the 
seizure that occurs before 
consciousness is lost and for which 
memory is retained. It varies from 
patient to patient, and includes 
somatosensory, auditory, visual, 
olfactory and gustatory symptoms; 
visceral sensations and complex 
subjective experiences. It may be very 
helpful in warning the patient that 
impairment of consciousness is 
imminent. It occurs in 50 to 83 percent 
of patients with CPS. 
The automatic behaviour of CPS may 
be the continuation of an activity that 
was in progress prior to the seizure 
(perseverative automatism) or may be 
new activity (de novo automatism). De 
novo automatism are further divided 
into reactive, in which the patient 
responds to external or internal 
environmental stimuli, and released, 
in which the patient carries out actions 
that are usually inhibited socially. 
Motor activities during automatisms 
are usually fragmentary, and rarely do 
well coordinated movements occur. 
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Types of automatisms that have been 
described include, alimentary, gestural, 
sexual automatisms, mimicry, ambulatory 
and verbal, ninety-five percent of adult 
patients with CPS would have 
automatisms. 
 Holmes divided CPS into 3 
types based on clinical manifestations 
and EEG features. In Type 1 CPS, the 
impairment of consciousness begins 
with a motionless stare and then is 
usually followed by automatic 
behaviour, while in Type II seizures 
the impairment of consciousness 
occurs at the same time as 
automatisms. Type III seizures are 
characterized by loss of body tone 
(drop attacks) followed by confusion, 
automatic behaviour, amnesia and 
gradual recomposure. Type I 
accounts for 40.6 percent while Type 
II, 50.7 percent and Type III, 8.7 
percent of CPS cases in children 47.  
 It is worth-noting that when 
seizures arise from the dominant 
hemisphere speech arrest is common, 
whereas involvement of the non-
dominant hemisphere may also result 
in speech arrest, but there may be 
perseveration of speech with 
continuous repeating of words or 
phrases. Autonomic symptoms may 
occur with both simple and complex 
partial seizures. Abdominal pain and 
vomiting usually occur in complex 
partial seizures. Somatosensory or 
special sensory symptoms occur with 
involvement of the cortical areas 
subserving sensory functions. Painful 
partial seizures are rare but have 
been well described 47. A headache 
rarely may be the sole ictal 
manifestation of both simple partial 
and complex partial seizure47. Psychic 
symptoms are usually components of  
complex partial seizures. 
Generalized Epilepsy 
 Generalized tonic - clonic 
(GTC) seizures constitute the largest 
subgroup of generalized epilepsies in 
Nigerian children 21,45. It accounted for 
between 25 and 65 percent of the 
generalized epilepsies in several 
series published in Nigeria28,45. 
Though, community based studies 
showed a higher prevalence of partial 
seizures over generalized, the latter is 
more prevalent in hospital admissions 
data2. There are two basic types; 
primary GTC seizures with bilaterally 
symmetrical involvement without focal 
features at onset, and secondary GTC 
seizures which begin focally and then 
become generalized. The latter 
accounted for 54.6 percent of 
generalized epilepsy in a Nigerian 
population7. Aura is common to the 
latter and the presence of aura is 
strongly indicative of a focal onset. 
GTC seizures may also occur in the 
reflex epilepsies. Reflex epilepsy 
describes a condition in which 
seizures are precipitated by clearly 
recognized stimuli. In reflex 
epilepsies, the seizures are either 
primary; in which seizures occur only 
following a specific stimulus, or 
secondary; in which there is an 
underlying seizure disorder and the 
seizure occurs at times other than as 
reflex phenomena. Reflex seizure is 
rare, occurring in approximately 5 per 
cent of patients with seizures48. 
 Photo sensitive epilepsy, a 
form of reflex epilepsy, is a 
photoconvulsive response to photic 
stimulation. It is frequently but not 
always associated with clinical 
seizures. The seizures, if present, are 
primarily generalized. It is present in 
40 percent of patients with absence 
seizures and 20 percent of patients 
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with GTC seizures. It is however rare 
in patients with partial seizures. 
Jeavons classified photosensitive 
epilepsy into two categories, namely; 
(i) pure photosensitive epilepsy, in 
which clinical seizures occur only 
when patient is exposed to a flickering 
light source and (ii) epilepsy with 
photosensitivity in which spontaneous 
seizures as well as those induced by 
flickering light occur49. Photosensitive 
epilepsy usually appears around 
puberty with a higher incidence 
among females (F/M 1.7:1). The 
occurrence of photoparoxysmal 
discharges to photic stimulation on 
EEG recordings tends to have a 
seasonal variation with lower 
incidence in summer, probably 
reflecting lower cerebral neuronal 
excitability and consequent less 
frequent discharges in summer than in 
winter50. The major precipitant of 
seizures is the television49. Photo 
sensitive epilepsy should be 
distinguished from self induced 
epilepsy. 
 Primary reading epilepsy was 
first described by Bickford et al in 
195751. Patient characteristically 
experiences myoclonic jerking of the 
jaw while reading. If the patient 
continues reading, a GTC seizure 
ensues. Initially, the patient has a 
feeling of jaw movement without 
actual movement then develops 
actual jerks before the tonic - clonic 
seizures. This process ceases when 
reading is discontinued. EEG is 
normal inter-ictally. Secondary 
reading epilepsy is less stereotyped in 
pattern. It may occur spontaneously or 
may be precipitated. Jaw jerking 
phenomenon is absent and EEG 
recording is abnormal even when 
patient is not reading. 
 In absence (Petit Mal) seizures, 
the hallmark is suppression of mental 
functions, usually to the point of 
complete abolition of awareness, 
responsiveness and memory. It starts 
abruptly without an aura, and lasts 
from a few seconds to half a minute 
but occasionally may last for over a 
minute. On going activity is 
interrupted, the patient changes facial 
expression and becomes transfixed 
(like a statue). Patient stares with a 
motionless distant expression. At the 
end of a seizure, the patient frequently 
returns to the gesture, sentence or 
other interrupted activity. Postictal 
fatigue does not occur although there 
may be momentary confusion owing 
to the `time loss'. This `time loss' may 
serve as a cue that a seizure 
occurred, even though there may be 
complete amnesia for ictal events. 
Absence seizures are rare among 
Nigerian epileptic patients, with an 
incidence of between 3 and 10 
percent20,21, though Danesi reported 
an incidence of 11.2 percent28 in a 
series. This variation may not be 
unrelated to patients’ selection criteria 
and availability of facilities to facilitate 
seizure classification. 
 Myoclonic seizures are brief, 
unexpected muscular contractions 
which are usually bilateral but 
asymetrical, occasionally unilateral. 
There is no disturbance of 
consciousness. It occurs on 
awakening or first hour after getting 
up in the morning. Sometimes it may 
be intense, throwing the patient to the 
ground. The primary epileptic 
myoclonus include; (i) Primary 
generalized epileptic myoclonus, (ii) 
Infantile spasms, (iii) Juvenile myoclonic 
epilepsy of Janz, (iv) Epilepsia 
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partialis continua and (v) As 
component of other seizure types. 
The Lennox - Gaustaut 
syndrome, a form of secondarily 
generalized epilepsy, is a mixture of 
seizure types frequently comprising 
tonic, tonic-clonic, atypical absences, 
head drops (which represent a form of 
atonic seizures) or myoclonic 
seizures. It constituted 2.4 percent of 
all generalised epilepsies in Nigeria 28. 
 The clinical manifestations of 
infantile spasm vary considerably. 
Some are characterized by brief head 
nods, while others consist of violent 
flexion of the trunk, arms and legs. 
The diagnosis may often be delayed, 
since parents and even the physician 
may not recognize spasms as 
seizures. The onset is usually in the 
first 2 years of life with peak age of 
onset between 4 and 6 months. The 
attacks may be as frequent as 50 - 
100 per day. It is frequently 
associated with mental retardation, 
and this is present in 90 percent of 
cases with EEG hypsarrythmia 47. 
 Febrile seizures occur between 
6 months and 5 years of age. 
Although there are some exceptions, 
children outside this age range are 
less likely to have febrile seizures 47. 
The prevalence is higher in blacks 
than in whites, and incidence is higher 
in boys than girls. The seizures may 
be of any type, although they are 
usually generalised tonic - clonic. By 
definition, fever precedes the onset of 
the seizures. The seizures usually 
occur early in the course of the febrile 
illness, and in some children the first 
indication to the parents of an illness 
is the seizure. Most studies agreed 
that children who have had one or 
more febrile seizures are at increased 
risk for the development of epilepsy. 
The risk of developing epilepsy 
following febrile seizures has been 
reported to vary from 2 to 57 percent. 
The variable findings result from the 
different methods used to select the 
patients with febrile seizures, varying 
definitions of febrile seizures and 
epilepsy, and the duration of follow-up 
of the populations. It has been 
documented that febrile seizures 
might predispose to complex partial 
seizures, especially when the seizures 
are recurrent, atypical (i.e. focal in 
origin, documented postictal paralysis 
or seizures lasting longer than 10 
minutes) and when a family history of 
febrile seizures is present. 
Investigations 
Despite the fact that the diagnosis of 
epilepsy is largely based on clinical 
data, the evaluation of patients with 
suspected seizures requires the use 
of investigative modalities such as 
electroencephalography and neuroimaging 
facilities. 
Electroencephalography 
 Electroencephalography (EEG) 
has played a crucial role in the 
formulation of our present concept of 
epilepsy. Epilepsy is sometimes 
regarded as a test case for assessing 
the clinical value of EEG as it is a 
disorder of cerebral function and EEG 
is a functional investigation. It can 
supply supportive evidence for the 
diagnosis of epilepsy and also provide 
critical clues to the classification of 
epileptic seizures and syndromes. In 
addition, it may help in anatomical 
localization of an underlying cerebral 
pathology, but neuroimaging techniques 
provide more useful information 
concerning structural abnormalities. 
EEG indirectly aids in the selection of 
appropriate antiepileptic drugs and, in 
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certain circumstances, also helps in 
formulating a prognosis, since it is 
extremely valuable in the determination 
of seizure type.  
 Most routine EEGs in epileptic 
patients are obtained in the interictal 
state and the diagnostically useful 
finding is the epileptiform patterns 
(EPs) which suggests the presence of 
real epileptogenic process, although 
not pathognomonic of epilepsy. 
Electro-encephalographic recordings 
do not consistently reveal epileptiform 
patterns. Only 30 to 50 percent of 
patients with probable epilepsy would 
have epileptiform patterns on the first 
EEG. If multiple recordings are 
obtained, however, that proportion 
increases to 92 percent52. Interictal 
EEG records of Nigerian patients with 
epilepsy compared with their British 
counterparts revealed that interictal 
abnormalities were less common in 
Nigerian (15.7 %) than in British 
(52.9%) patients 53. This was 
attributed to the larger amount of 
sunshine present in the tropics.  
Out of 626 epileptic patients studied 
for presence of EP on EEG in Ibadan, 
only  46 percent showed these 
patterns and the proximity of seizures 
to EEG examination, the age of onset 
of seizures and duration of epilepsy 
were significantly correlated to the 
occurrence of the EPs 54. In an earlier 
study, by Osuntokun et al 55 in Ibadan, 
little or no correlation was found 
between the clinical types of epilepsy 
and the EEGs findings, although more 
than 70 percent of 560 patients 
studied demonstrated abnormalities 
on the EEG recordings. Ahmed et al 45 
reported normal EEG recordings in 
35.6 percent of 351 patients in 
Kaduna while Danesi 28 recorded lack 
of normal findings in all 945 patients 
studied in Lagos. 
 In specialized epilepsy centres, 
depth electrodes, nasopharyngeal and 
sphenoidal electrodes, are now being 
used to facilitate the demonstration of 
EPs52, due to temporal lobe abnormalities. 
In patients with unclassifiable seizures, 
video recording of attacks with 
simultaneous EEG recordings are 
employed to facilitate direct 
observation of seizures. 
Neuro-imaging 
Computerized Tomography 
 With the introduction of the 
computerized tomography (CT) in the 
1970s, the practice of neuroradiology 
and clinical neurology has been 
transformed. It is very useful in the 
detection of structural lesions and the 
determination of the exact location of 
such lesions. It is also used in the 
determination of cerebral atrophy, 
which is the commonest abnormality 
demonstrated in epileptic patients 56. 
The importance of CT was 
established at the 21st European 
Congress of Electroencephalography 
and Epilepsy in 1975, where CT 
features in 1702 selected patients 
were presented with 45 percent 
exhibiting cerebral atrophy 57. The 
proportion of abnormalities on CT is 
higher in late onset epilepsy as 
localization - related epileptic 
syndromes are commoner in the adult 
population 56,58. A descriptive study of 
103 consecutive children with epilepsy 
for over 5 year period showed 
abnormal films in 51.5% with most 
patients having hydrocephalus 
followed by cerebral atrophy and 
infarct. A high incidence of abnormal 
findings was reported in those with 
partial seizures 59. The CT findings in 
75 adult Nigerian patients reported by 
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Ogunniyi et al 60 showed normal 
findings in 54.7 percent, cerebral 
atrophy in 21.3% while cerebral 
tumours, vascular lesions and 
porencephaly accounted for the 
remaining. 
Plain Radiology 
 Plain skull X-ray still has a 
definite place57 in developing 
countries although the development of 
advanced imaging techniques has 
made it almost irrelevant. It is still 
cheap, widely available and relatively 
innocuous despite its inferiority in both 
sensitivity and specificity to newer 
techniques. It is useful in the detection 
of bony changes (as seen in raised 
intracranial pressure and some 
tumours) and abnormal calcification 
(commonly associated with cerebral 
tumours, arteriovenous malformations 
and infections like cysticercosis, 
toxoplasmosis and cytomegalovirus). 
Positron Emission Tomography 
(PET) 
 This technique has, at present, 
few applications in the evaluation of 
epileptic patients. In interictal studies 
of patients with complex partial 
seizures, focal glucose hypometabolism 
in the abnormal temporal lobe is a 
relatively consistent finding. There is 
also correlation between degree of 
cell loss on pathologic examination of 
the surgically removed temporal lobe 
and the degree of hypometabolism. It 
is usually indicated in patients 
considered for temporal lobectomy in 
some centres. Using 18Fluorine-labelled 
glucose studies, increased diffuse 
utilization has been demonstrated in 
absence seizures. 
 
Single Photon Emission Computerized 
Tomography (SPECT) 
 This is also not commonly used 
in the evaluation of epilepsy. It is both 
a structural and functional 
neuroradiological investigation as it 
reveals the presence of structural 
lesions and disturbances in 
metabolism. It utilises radioisotope 
scanning to delineate cerebral 
perfusion and structural abnormalities. 
Magnetic Resonance Imaging (MRI) 
 This technique is superior to 
CT in the detection of most structural 
lesions, including tumours, and 
especially in the evaluation of 
demyelinating diseases, lesions in the 
posterior fossa and many white matter 
disorders. It is not easily available in 
many developing countries. MR 
spectroscopy is however superior to 
MRI in delineating the cellular damage 
in demyelinating diseases. In patients 
suffering from intractable temporal 
lobe epilepsy, in whom pre-surgical 
localization of the epileptic focus is 
one of main problems, studying the 
seizure pattern and EEG findings 
complemented by MRI results and 
neuropsychological assessment have 
proved inadequate. MR spectroscopy 
has proved superior in pre-surgical 
localization. MR spectroscopy has 
been used to detect N - acetyl 
aspartate reduction in the affected 
temporal lobe and this positively 
correlates with clinical EEG and 
structural lateralization.   
Other neuroradiological investigations 
are employed less frequently as a 
result of the introduction of CT and 
MRI scanning. The  older methods of 
injecting air either into the cerebral 
spinal fluid via a lumbar puncture (air 
encephalogram) or directly into the 
ventricle via a needle inserted through 
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a burr hole in the skull (air 
ventriculogram) has been superceded 
by CT scanning. Cerebral angiography 
retains an important place in the 
investigation of intracranial tumours 
and vascular lesions. Radio-isotope 
brain scan is no longer commonly 
used, due to high false negative rates, 
in the detection of brain tumours. 
 Biomagnetic imaging, however, 
using biomagnetometer provides 
information about the body's electrical 
activity, and is entirely non-invasive 
and can map the sources of electrical 
activity in three dimensions with 
resolution. It is of potential in the 
diagnosis of epilepsy. Most of these 
facilities especially the functional 
imaging techniques are not available 
in Nigeria. The investigations of PWE 
in Nigeria are limited to CT brain 
scans and MRI. 
Treatment 
 Epilepsy is a neurological 
disease, which is primarily diagnosed 
medically and as a rule treated by 
pharmaco-therapy except in cases of 
refractory epilepsy that may sometimes 
require surgical intervention. Treatment 
with an antiepileptic drug is usually 
begun when the patient has had more 
than one unprovoked seizure within a 
year, whatever the type. Most patients 
with recurrent epileptic seizures 
require treatment. The question of 
whether to treat a single seizure is 
controversial61. The single attack of 
seizure may be provoked and there 
are cases when episodes are 
separated by years. It is however 
important to note that patients who 
have had unprovoked seizure have a 
substantial chance of recurrent events 
i.e. epilepsy, with the frequency 
ranging from 31 to 71 percent 
depending on other risk factors61,62. It 
is advised that patients with an 
underlying neurologic abnormality or 
cerebral lesion or a specific syndrome 
such as juvenile myoclonic epilepsy 
should be treated62. 
Drug Therapy 
 The diagnosis of epilepsy has 
profound implication to the sufferer, 
not least of which is the fact that 
medication may have to be taken 
every day for many years. The drugs 
may cause toxic side effects, require 
continual medical supervision and 
may have complex psychosocial 
consequences. Therefore the decision 
to initiate drug treatment requires that 
the diagnosis of epilepsy must be 
certain, and estimates of the chances 
of seizure recurrence must be made 
and the extent to which anticonvulsant 
therapy will improve these chances be 
considered. This decision about 
treatment should be made after an 
extensive discussion with the patient 
about the cost, the risk and benefits of 
treatment and the risk associated with 
no therapy. The best drug for the 
particular type of seizure is selected 
and administered in a dose high 
enough to bring the plasma drug 
concentration into a therapeutic range 
without unacceptable side effects. The 
goal should be restoration of a normal 
life through complete control of 
seizure with the use of a single drug 
that has no side effects. 
 Drug compliance must be 
emphasized. Among 345 adult 
Nigerians with epilepsy, only 25.5% 
complied with therapy while 107 
patients defaulted. It is not unusual to 
find patients with epilepsy seeking 
alternative treatment methods in 
Nigeria 22, and this probably explain 
late presentation in the hospital, high 
default rate and frequent presentations 
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with status epilepticus in the emergency 
rooms. The study by Danesi and 
Adetunji 63 reported a 47.6% usage of 
African traditional medicine and 
24.1% combined usage of traditional 
and spiritual methods. These groups 
of patients used these methods for 1 – 
5 years before seeking help in the 
hospitals. 
 Carbamazepine, Phenytoin, valproic 
acid, phenobarbital and primidone are 
all effective in reducing the frequency 
of partial seizures. There are, 
however, conflicting data on whether 
carbamazepine is more effective than 
valproic acid64,65. Notwithstanding, 
Carbamazepine and Phenytoin are 
the drugs of choice for partial 
seizures.  For patients with tonic - 
clonic seizures, valproic acid, 
phenytoin and carbamazepine are all 
effective. 
Valproic acid is the drug of choice for 
patients with tonic - clonic seizure, 
and spike - wave discharge on the 
electroencephalogram and for 
patients with other forms of 
generalized epilepsy, particularly 
myoclonic jerks and absence 
seizures. Ethosuximide is also a 
useful drug for absence seizures. For 
patients who have both absence 
seizure, and tonic-clonic seizures or 
myoclonic jerks, valproic acid is 
preferable. 
 Carbamazepine was strongly 
recommended by Familusi 66 in the 
management of seizure disorders, 
especially intractable seizures, in 
Nigeria despite its high cost and 
limited availability a decade ago. It 
has however gained wide acceptance 
due to its favourable anticonvulsant 
efficacy and supplementary psychotropic 
use. Treatment with carbamazepine 
should be initiated at low doses (200 
to 400 mg daily) to allow development 
of tolerance. The dose can then be 
increased by increments of 200mg per 
day at intervals of two to four weeks 
until a maintenance dose has been 
reached that controls the seizure 
disorder completely. The final dose 
often depends on the extent to which 
carbamazepine induces its own 
metabolism. 
In some patients, high peak plasma 
concentrations can result in 
intermittent central nervous system 
side effects about two hours following 
administration of the drug three or four 
times daily. This problem can be 
overcome by prescribing a controlled - 
release formulation which can be 
given once or twice daily, although 
this is fairly expensive but readily 
available in Nigeria.  
In addition to inducing its own 
metabolism, carbamazepine can 
accelerate the hepatic oxidation and 
conjugation of other lipid - soluble 
drugs. The most common interaction 
is with oral contraceptive pills and 
most women require an increase in 
the daily dose of oestrogen from 35 to 
50ug or more. It also accelerates the 
metabolism of valproic acid, ethosuximide, 
corticosteroids, anticoagulant and 
antipsychotic drugs, and paradoxically, 
whereas phenytoin induces the 
metabolism of carbamazepine, 
carbamazepine inhibits the metabolism 
of phenytoin. Thus adding phenytoin 
decreases plasma carbamazepine 
concentration by about a third, 
whereas adding carbamazepine increases 
plasma phenytoin concentration by a 
similar amount. Drugs like cimetidine, 
erythromycin, isoniazid verapamil, 
propoxyphene and dilitiazem inhibit 
metabolism of carbamazepine sufficiently 
to cause toxic effects. 
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 Phenytoin is effective for the 
treatment of partial and tonic - clonic 
seizures. It appears to act by inducing 
voltage dependent blockade of 
sodium channels. A starting dose of 
5mg per kilogram of body weight 
raises plasma concentrations within 
the target range of 10 to 20ug per 
milliliter in most patients, but some will 
have higher concentrations and 
neurotoxic effects. Some patients 
require a higher dose, for example, 
those who abuse alcohol and have 
increased hepatic microsomal enzyme 
activity. The dose can be increased, in 
general, by 100mg if the plasma 
concentration is 5ug per milliliter or 
less, but no more than 50mg should 
be added if the plasma drug 
concentration is higher. Some patients 
can benefit from plasma concentrations 
above 25ug per milliliter without 
adverse effects. 
 Phenytoin can induce the 
oxidative metabolism of many lipid - 
soluble drugs including carbamazepine, 
valproic acid, ethosuximide, anticoagulant 
agents, corticosteroid and cylosporine. 
Drugs like allopurinol, amiodarone, 
cimetidine, imipramine and some 
sulfonamides, inhibit the metabolism 
of phenytoin. 
 Phenobarbitone is as effective 
as phenytoin and carbamazepine in 
abolishing partial and generalised 
tonic - clonic seizures. The drug, at 
the cellular level, prolongs inhibitory 
postsynaptic potentials by increasing 
the mean chloride - channel opening 
time and hence the duration of 
gamma - aminobutyric acid - induced 
bursts of neuronal activity. This drug 
has been successfully used to treat 
epilepsy by primary health workers in 
rural Africa and this is likely to 
continue. Good seizure control was 
reported in 52.9% of children with 
epilepsy by Sykes 67 in Benin City, 
Nigeria but the response to 
medication was less satisfactory for 
children under one year. In a study 
that assessed the effectiveness of 
anticonvulsant therapy among 175 
Nigerian patients with epilepsy, 
phenobarbital was the single most 
commonly prescribed agent due to 
economic considerations, availability 
and favourable seizure control 68. 
Furthermore, the WHO recommended 
phenobarbital as the drug of choice in 
the management of seizures in 
developing countries39. 
To minimize the sedative effect the 
starting dose should be low i.e. 60mg 
in adults and 4mg per kilogram of 
body weight in children, and increased 
gradually according to the response. 
The value of measuring plasma 
phenobarbital concentration is limited, 
because the concentration associated 
with optimal control varies considerably61. 
In addition, the development of tolerance 
to the drug's central nervous system 
side effects makes the toxic threshold 
imprecise. The main limitation of 
phenobarbital is its propensity to alter 
cognition69, mood and behaviour. It 
can cause fatigue and listlessness in 
adults. Memory, mood and learning 
capacity may be subtly impaired69. 
Depression, arthritic changes and 
Duputyren's contracture can be 
associated problems. Tolerance to the 
deleterious cognitive effects of 
phenobarbital can develop, but 
unfortunately, tolerance to its 
anticonvulsant effect can also develop. 
Phenobarbital is the archetypal 
enzyme inducer and can accelerate 
the metabolism of many lipid - soluble 
drugs. 
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Primidone is metabolized to phenobarbital 
and another active metabolite, 
phenylethylmalonamide. The efficacy 
of primidone is similar to that of 
phenobarbital, but primidone is less 
well tolerated 64. 
 The anticonvulsant properties 
of valproic acid were first reported in 
1961, but it is only in the past 15 
years that the drug has attracted wide 
interest. It is effective in patients with 
idiopathic generalized epilepsy. The 
drug acts by limiting sustained 
repetitive neuronal firing through 
voltage - and use - dependent 
blockade of sodium channels, 
although it is also likely to have other 
effects. The starting dose for adults 
and adolescent is 500mg once or 
twice daily, with subsequent increases 
according to the response. Because 
valproic acid can take several weeks 
to become fully effective, the dose 
should not be increased sooner. 
Routine plasma concentration 
monitoring is not helpful as there is no 
clear-cut relation among the plasma 
concentration, its effect and toxicity, 
and since the daily variation in plasma 
concentration is wide.  
 Common side effects are dose-
related tremor, weight gain due to 
appetite stimulation, thinning or loss of 
hair (usually temporary) and menstrual 
irregularities including amenorrhea. 
Approximately 20 percent of all 
patients receiving the drug have 
hyperammonemia without hepatic 
damage. This effect is usually 
asymptomatic but occasionally can 
cause confusion, nausea and 
vomiting61. Valproic acid inhibits 
several hepatic metabolic processes 
including oxidation, conjugation and 
epoxidation. Aspirin displaces valproic 
acid from its binding sites on plasma 
proteins and inhibits its metabolism. 
Valproic acid does not interfere with 
the action of oral contraceptives. 
 The first reports of clonazepam 
use in epilepsy were made in 1970 
and since then there have been a 
number of clinical studies. 
Clonazepam is effective in preventing 
absence seizures, myoclonic jerks 
and tonic - clonic seizures. It is also 
very useful in the treatment of status 
epilepticus. As with other benzodiazepines, 
however, the sedative effect and the 
development of tolerance substantially 
reduces its usefulness. Few patients 
have good responses, and in nearly 
50 per cent of patients, the epilepsy is 
exarcebated when the drug is 
withdrawn 70. The therapeutic role of 
clonazepam is therefore limited, and it 
is used mostly for refractory myoclonic 
seizures. 
 Ethosuximide is highly effective 
against petit mal (typical absence) 
seizures. It acts by reducing low - 
threshold, transient, voltage - 
dependent calcium conductance in 
thalamic neurons. In children older 
than six years, 500mg daily is a 
reasonable starting dose, with further 
increments as necessary to a  
maximum of 1 to 2gm daily. For most 
patients the dose can be increased 
every two to four weeks, but more 
rapid titration may be needed.  
The side effects of ethosuximide 
usually involve the gastro intestinal 
tract (nausea, vomiting and abdominal 
pain) or central nervous system 
(lethargy, dizzines and ataxia). These 
problems are often not correlated with 
high plasma concentration of the drug. 
The metabolism of ethosuximide is 
altered by enzyme inducers such as 
phenytoin and carbamazepine and by 
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enzyme inhibitors such as valproic 
acid. 
Treating Refractory Seizures 
 In about 30 percent of patients 
with epilepsy, the seizures are 
refractory to treatment with a single 
antiepileptic drug 71. Many of these 
patients have partial seizures due to 
an underlying anatomical lesion, and 
the addition of other drugs is 
successful only about 10 percent of 
the time 61,71. Before long-term 
treatment with more than one drug is 
undertaken, all reasonable options for 
monotherapy should be exhausted. 
The diagnosis of epilepsy should be 
reassessed in all patients with 
resistant seizures before assuming 
the seizures to be intractable. Even in 
specialist epilepsy clinics, the seizures 
in up to 20 percent of such patients 
may prove to be non-epileptic in 
origin. Also, the cause of the epilepsy 
should again be considered, and 
progressive cerebral disease 
excluded. 
 Furthermore, a complete 
treatment history should be taken as 
in most chronic cases the previous 
response to an individual drug is a 
useful guide to any future response. 
Information should be obtained 
regarding the drugs previously taken, 
the duration of therapy, the maximum 
dosage and serum levels, and 
compliance. If one drug is ineffective, 
an alternative drug should be 
introduced gradually. If the patient has 
a response to the second drug, an 
attempt should be made to withdraw 
the original drug. Only if this attempt is 
unsuccessful, should two-drug 
therapy be continued. No controlled 
clinical trials have identified the best 
second drug or combination of drugs 61. 
For patients with partial or tonic-clonic 
seizures, most specialists used two of 
the three first-line drugs - namely, 
carbamazepine, valproic acid or 
phenytoin, for combination therapy 
although their mechanisms of action 
overlap. Patients with myoclonic 
seizures who do not have a response 
to valproic acid, clonazepam may be 
added, whereas patients with 
intractable typical or atypical absence 
seizure may have a response to 
valproic acid combined with 
ethosuximide. Many patients receive 
treatment with three or more 
antieplieptic drugs when their seizures 
are intractable, although few are 
made free of seizures by this 
approach. The likelihood of toxic 
effects, especially cognitive dysfunction, 
increases with the number of epileptic 
drugs prescribed61. Also it may be 
counter productive to introduce a 
sedative drug such as phenobarbital 
or primidone, because if the drug is 
ineffective, its subsequent withdrawal 
will probably decrease the control of 
seizure. 
 The addition of one of the 
newer drugs - lamotrigine, gabapentin, 
vigabatrin, clobazam, oxcarbazepine 
or felbamate - may be more 
appropriate. Studies of vigabatrin 
(gamma-vinyl GABA), a GABA 
analogue, have reported that 33 - 
62% of patients with intractable 
epilepsy experience a greater than 
50% reduction in seizures; patients 
with partial epilepsy have the highest 
success rates 72,73, when given 
vigabatrin at doses of 2 - 3 g/ day. 
Other GABA agonists that are 
undergoing clinical trials include 
stiripentol and progabide. Zonisamide, 
a sulphonamide drug, and the 
imidazole derivatives - denzimol and 
Vol. 8 No. 1 December 2006 Epilepsy in Nigeria - a review of etiology, epidemiology  
 45
nafimidone are also being tried. A 
cinnarizine derivative, fluzarine, and 
several new barbiturate drugs such as 
cinromide, ralitoline, mexiletine and 
fluzinamide, are also being investigated 
in the treatment of refractory seizures 74. 
 Other miscellaneous antieplieptic 
medication in use, though rarely, 
include Beclamide (a propionamide 
derivative introduced in 1953) 
reported to be efficacious in grand mal 
and complex partial epilepsy; 
paraldehyde (a polymer of 
acetaldehyde which is poorly water 
soluble) used since 1882 as 
intramuscular emergency treatment 
for acute epilepsy and intravenously 
for status epilepticus; and 
corticosteroid drugs, especially 
Adrenocorticotrophic hormone 
(ACTH), occasionally used in 
epilepsy, especially in infantile 
spasms with often an immediate 
response. 
Withdrawing medication 
 In more than 60 percent of 
patients who remain free of seizures, 
the medication can eventually be 
withdrawn successfully75. Some 
physicians wait for two years, and 
others for five. Most advise a slow 
reduction in the dose of each drug 
during a period of two to six months. 
Children who have benign epilepsy 
with rolandic spikes or benign familial 
neonatal convulsions usually do well 
after drug withdrawal whereas those 
with juvenile myoclonic epilepsy often 
have relapses. 
 Patients with idiopathic generalized 
seizures, whether absence or tonic - 
clonic seizures are least likely to have 
a recurrence after control has been 
achieved and medication withdrawn. 
Even complex partial seizures can 
disappear, after a long period of 
control. The patients with the highest 
probability of remaining free of 
seizures after the medication has 
been discontinued are those  who 
have had no seizures for a long 
period, those who had few seizures 
before control was achieved and 
those with a normal neurological 
examination and no structural brain 
lesion. 
Surgical Management 
 Patients who continue to have 
seizures despite good drug 
compliance may sooner require the 
surgical option. Such patients should 
be referred to an epilepsy center for 
several reasons. First, the more 
seizures a patient has, the more 
difficult it is to control the epilepsy, 
that seizures may beget seizures has 
been hypothesized for more than a 
century 12. Second, it may be hard to 
classify the seizures on the basis of 
accounts given by untrained 
eyewitnesses making video 
electroencephalographic monitoring 
useful in arriving at a definitive 
diagnosis and classification. In some 
patients, apparently uncontrolled 
seizures are really pseudo-seizures 
which video EEG monitors will show 
and such patients are better treated 
with psychotherapy. Third, patients 
with uncontrolled seizures often 
receive multiple drugs, which may 
have substantial toxic effects that can 
be reduced by simplification of the 
regimen. Fourth, in patients who have 
not had adequate responses to the 
standard drugs, there may be an 
opportunity to try an experimental 
drug. Finally, appropriate decisions 
about surgical treatment are best 
made at a specialized center. 
 The surgical therapy for 
epilepsy has focused mainly on 
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temporal lobectomy. The excision of 
the anterior temporal lobe in one block 
as practised by the Maudsley group 
has been improved upon by the 
Zurich group who practised 
microsurgical, selective amygdalo 
hippocampectomy. Various centres 
reported a 60 - 80% success rate with 
cessation of seizures in about 50% 
and very significant reduction in 
frequency in about 30% 76. 
 Division of the corpus callosum 
was occasionally performed to 
prevent spread of seizure discharges 
from one hemisphere to the other 77 
however the Yale group reported that 
some patients experience more 
intensive focal seizures after the 
procedure 78. Stimulation of the 
cerebellum has been reported to 
suppress seizures 79, but this has not 
gained acceptance in clinical circles. 
There are no published data on 
epilepsy surgery in Nigerians and 
epilepsy surgery is non-existent in 
98% of African countries80. This is an 
area of challenges for neurosurgical 
practice in our country where epilepsy 
is common. 
Dietary Management 
 Ketogenic diets have been 
occasionally used in the management 
of intractable epilepsy since Wilder's 
original report in 1921 81. The classical 
diet is based on an estimated daily 
requirement of 75 kilocalories per 
body weight; 50% of calories are 
given as fat, the remainder as protein 
and carbohydrates. The fats are 
mainly long chain fats such as butter 
and cream. Medium chain 
triglycerides (MCT), largely octanoic 
and decanoic acids, have been used 
in some centers. In a study from 
Oxford 82, 41% of 57 children with 
epilepsy showed a greater than 90% 
reduction in seizure frequency within 
one month of starting the diet. 81% of 
the children had a greater than 50% 
reduction in seizure frequency, and 
only 19% showed no benefit. There is 
no report of this therapeutic option 
among Nigerian patients. 
Quality of life among patients with 
epilepsy 
 Quality of life among patients 
with chronic epilepsy has been little 
study among Nigerians. Main aspect 
of life events affected from a study 
done in Ibadan 83 was feeling of 
energy deficits. This was closely 
followed by memory, fear of 
experiencing the next seizure and 
work and social limitations.  Cognitive 
impairments due either to the 
recurrent seizures 84,85 or the anti-
epileptic drugs contribute to disruption 
of life quality 69, 71,.  The social 
problems encountered by 
schoolchildren with epilepsy as a 
result of negative attitudes and beliefs 
are enormous. The school teachers’ 
perception plays a significant role in 
the approach to care of the affected 
students. A study86 demonstrated that 
despite the fairly high level of 
education among the teachers in 
Nigeria the mean overall score for 
correct response for knowledge on 
epilepsy was 52.9%, and majority of 
these teachers had negative attitudes 
and beliefs.  
There is an urgent need for public 
awareness and education with the 
objective of eradicating the stigma 
attached to epilepsy and getting the 
community and primary health care 
workers actively involved in the 
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